These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9097903)

  • 41. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.
    Canaday DH; Chakravarti S; Srivastava T; Tisch DJ; Cheruvu VK; Smialek J; Harding CV; Ramachandra L
    Cell Immunol; 2006 Oct; 243(2):96-106. PubMed ID: 17324388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
    Umetsu DT; Katzen D; Jabara HH; Geha RS
    J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen-presenting capacity of rheumatoid synovial fibroblasts.
    Boots AM; Wimmers-Bertens AJ; Rijnders AW
    Immunology; 1994 Jun; 82(2):268-74. PubMed ID: 7927499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are naïve T cells and class-switched memory (IgD
    Shigeta N; Nakamura H; Kumasawa K; Imai K; Saito S; Sakaguchi S; Kimura T
    Med Hypotheses; 2018 Dec; 121():36-41. PubMed ID: 30396484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiency.
    Keller B; Cseresnyes Z; Stumpf I; Wehr C; Fliegauf M; Bulashevska A; Usadel S; Grimbacher B; Rizzi M; Eibel H; Niesner R; Warnatz K
    J Allergy Clin Immunol; 2017 Jan; 139(1):220-231.e8. PubMed ID: 27461466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-cell-T-cell activation and interaction in common variable immunodeficiency.
    Rezaei N; Wing JB; Aghamohammadi A; Carlring J; Lees A; Asgarian-Omran H; Pourpak Z; Sarrafnejad A; Kardar GA; Shahrestani T; Masoumi F; Zare A; Saghafi S; Sarrafzadeh S; Foster RA; Heath AW; Read RC
    Hum Immunol; 2010 Apr; 71(4):355-62. PubMed ID: 20097245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications.
    Vodjgani M; Aghamohammadi A; Samadi M; Moin M; Hadjati J; Mirahmadian M; Parvaneh N; Salavati A; Abdollahzade S; Rezaei N; Srrafnejad A
    J Investig Allergol Clin Immunol; 2007; 17(5):321-8. PubMed ID: 17982925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient.
    Geha RS; Rosen FS
    J Immunol; 1989 Jul; 143(1):84-8. PubMed ID: 2567317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elimination of monocytes from cultures activated with recall antigens.
    Pryjma J; Zembala M; Baran J; Ernst M; Flad HD
    Immunol Lett; 1995 Jun; 46(3):229-35. PubMed ID: 7590940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID).
    Ganjalikhani-Hakemi M; Yazdani R; Esmaeili M; Abolhassani H; Rae W; Azizi G; Dizaji MZ; Shaghaghi M; Rezaei A; Abbasi-Rad F; Afshar-Qasemloo S; Mohammadi S; Rezaei N; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2017 Nov; 17(4):332-340. PubMed ID: 28925897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Tseng TY; Lin YL
    Ann Med; 2014 Nov; 46(7):555-65. PubMed ID: 25109505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigen presenting cells and mechanisms of antigen presentation.
    Chesnut RW; Grey HM
    Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of 17 beta-oestradiol on function of lymphocytes from normal donors and patients with common variable immunodeficiency (CVID).
    Evagelatou M; Webster AD; Farrant J
    Clin Exp Immunol; 1994 Nov; 98(2):203-9. PubMed ID: 7955523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.